[go: up one dir, main page]

IL156334A0 - Methods for the production of multimeric proteins, and related compositions - Google Patents

Methods for the production of multimeric proteins, and related compositions

Info

Publication number
IL156334A0
IL156334A0 IL15633401A IL15633401A IL156334A0 IL 156334 A0 IL156334 A0 IL 156334A0 IL 15633401 A IL15633401 A IL 15633401A IL 15633401 A IL15633401 A IL 15633401A IL 156334 A0 IL156334 A0 IL 156334A0
Authority
IL
Israel
Prior art keywords
production
methods
related compositions
multimeric proteins
multimeric
Prior art date
Application number
IL15633401A
Other languages
English (en)
Original Assignee
Sembiosys Genetics Inc
Syngenta Participations Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sembiosys Genetics Inc, Syngenta Participations Ag filed Critical Sembiosys Genetics Inc
Publication of IL156334A0 publication Critical patent/IL156334A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
IL15633401A 2000-12-19 2001-12-19 Methods for the production of multimeric proteins, and related compositions IL156334A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74290000A 2000-12-19 2000-12-19
US30288501P 2001-07-05 2001-07-05
US603801A 2001-12-04 2001-12-04
PCT/US2001/050240 WO2002050289A1 (fr) 2000-12-19 2001-12-19 Procedes de production de proteines multimeriques, et compositions associees

Publications (1)

Publication Number Publication Date
IL156334A0 true IL156334A0 (en) 2004-01-04

Family

ID=27358025

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15633401A IL156334A0 (en) 2000-12-19 2001-12-19 Methods for the production of multimeric proteins, and related compositions

Country Status (15)

Country Link
US (1) US20090197337A1 (fr)
EP (1) EP1346056A1 (fr)
JP (1) JP4570327B2 (fr)
KR (1) KR20030066732A (fr)
CN (1) CN100385005C (fr)
AR (1) AR037083A1 (fr)
AU (2) AU3281902A (fr)
BR (1) BR0116220A (fr)
CA (1) CA2432315A1 (fr)
EA (1) EA009181B1 (fr)
IL (1) IL156334A0 (fr)
MX (1) MXPA03005548A (fr)
NZ (1) NZ526822A (fr)
TW (1) TWI317736B (fr)
WO (1) WO2002050289A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7009087B1 (en) 2000-12-01 2006-03-07 Pioneer Hi-Bred International, Inc. Compositions and methods for altering the disulfide status of proteins
WO2002090300A2 (fr) * 2001-05-04 2002-11-14 Xencor Acides nucleiques et proteines presentant une activite de thioredoxine reductase
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
EA014887B1 (ru) * 2003-06-17 2011-02-28 Сембайосиз Джинетикс Инк. Способ экспрессии инсулина в семенах растения, способ получения семян растений, содержащих инсулин, и растения, способные производить семена, содержащие инсулин
TW200526778A (en) * 2003-11-14 2005-08-16 Sembiosys Genetics Inc Methods for the production of apolipoproteins in transgenic plants
JP4160615B2 (ja) * 2004-03-11 2008-10-01 レドックス・バイオサイエンス株式会社 プロテアーゼ阻害剤
JP2006151861A (ja) * 2004-11-29 2006-06-15 Redox Bioscience Inc 喫煙によって引き起こされる臓器障害の予防乃至治療剤
GB0524884D0 (en) * 2005-12-06 2006-01-11 Syngenta Ltd Improvements in or relating to organic compounds
EP2573178A3 (fr) * 2007-07-10 2013-07-24 Monsanto Technology LLC Plantes transgéniques dotées de traits agronomiques améliorés
JP2011516548A (ja) * 2008-04-11 2011-05-26 セムバイオシス ジェネティクス インコーポレイテッド オレオソームからの活性薬剤の制御放出
ES2354537B1 (es) * 2008-06-27 2012-01-23 Universidad Pública de Navarra Tiorredoxinas plastidiales: sobreexpresión y aplicaciones biotecnológicas.
ES2384777B1 (es) * 2008-06-27 2013-06-19 Universidad Pública de Navarra Tiorredoxinas plastidiales: sobreexpresión y aplicaciones biotecnológicas.
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
US9745362B2 (en) 2009-12-09 2017-08-29 Shengjun An Seed-specific expression vector and its construction methods and applications
CN103343138B (zh) * 2013-07-10 2016-07-13 吉林农业大学 一种含有酸性成纤维细胞生长因子活性多肽的植物油体护肤乳液
CN103333915B (zh) * 2013-07-10 2015-08-05 吉林农业大学 一种含有碱性成纤维细胞生长因子活性多肽的植物油体护肤乳液
CN103343137B (zh) * 2013-07-10 2015-05-20 吉林农业大学 一种含有表皮生长因子活性多肽的植物油体护肤乳液
KR101831888B1 (ko) * 2016-04-15 2018-04-16 (주)케어젠 항염증 활성을 갖는 펩타이드 및 이의 용도
CN106905435B (zh) * 2017-03-13 2020-04-10 武汉海沙百得生物技术有限公司 一种制备基于蛋白a突变体的结合蛋白的方法
US20200172948A1 (en) * 2017-07-19 2020-06-04 Alcantara Research Group Inc. Recombinant polypeptide enriched algal chloroplasts, methods for producing the same and uses thereof
JP6923166B2 (ja) * 2019-07-16 2021-08-18 住友ゴム工業株式会社 融合タンパク質、物質製造方法、ベクター、形質転換細胞、空気入りタイヤの製造方法及びゴム製品の製造方法
EP4103729B1 (fr) * 2020-04-03 2023-10-18 Wacker Chemie AG Biocatalysateur comme composant principal d'un système redox catalysé par des enzymes pour la réduction biocatalytique de la cystine
EP4060045A1 (fr) * 2021-03-16 2022-09-21 Core Biogenesis Plante génétiquement modifiée ou une partie de celle-ci adaptée pour la production de protéines recombinantes et procédé associé
JPWO2022270588A1 (fr) * 2021-06-23 2022-12-29
AU2022202825B1 (en) * 2022-04-28 2023-09-07 AUSTRALIAN HEALTH INDUSTRY Co. PTY LTD Polypeptide, polypeptide composition and application, and prepared anti-wrinkle lotion thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US4771036A (en) * 1986-02-10 1988-09-13 Trustees Of Columbia University In The City Of New York Method and ophthalmic composition for the prevention and reversal of cataracts
US4954618A (en) * 1986-02-14 1990-09-04 Genex Corporation Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G
CA2044296A1 (fr) * 1990-06-12 1991-12-13 Hiroaki Okamoto Amorces d'oligonucleotides, leur application dans la detection haute-fidelite des virus de l'hepatite non-a et non-b
US6288304B1 (en) * 1991-02-22 2001-09-11 Sembiosys Genetics Inc. Expression of somatotropin in plant seeds
US7091401B2 (en) * 1991-02-22 2006-08-15 Sembiosys Genetics Inc. Expression of epidermal growth factor in plant seeds
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US6750046B2 (en) * 1991-02-22 2004-06-15 Sembiosys Genetics, Inc. Preparation of thioredoxin and thioredoxin reductase proteins on oil bodies
US5948682A (en) * 1991-02-22 1999-09-07 Sembiosys Genetics Inc. Preparation of heterologous proteins on oil bodies
US5792506A (en) * 1991-10-12 1998-08-11 The Regents Of The University Of California Neutralization of food allergens by thioredoxin
AU678154B2 (en) * 1992-04-02 1997-05-22 Sembiosys Genetics Inc. Oil-body protein cis-elements as regulatory signals
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
JPH0912471A (ja) * 1995-06-29 1997-01-14 Noevir Co Ltd 皮膚外用剤
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US7585645B2 (en) * 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
US6183762B1 (en) * 1997-05-27 2001-02-06 Sembiosys Genetics Inc. Oil body based personal care products
US6599513B2 (en) * 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
CA2291274C (fr) * 1997-05-27 2006-05-16 Sembiosys Genetics Inc. Utilisations de corps huileux
US6761914B2 (en) * 1997-05-27 2004-07-13 Sembiosys Genetics Inc. Immunogenic formulations comprising oil bodies
JP2000103743A (ja) * 1998-09-29 2000-04-11 Jiyunji Yodoi チオレドキシン活性を有するファミリーに属するポリペプチド類を含有する食品、化粧品及び医薬
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
TW200526778A (en) * 2003-11-14 2005-08-16 Sembiosys Genetics Inc Methods for the production of apolipoproteins in transgenic plants

Also Published As

Publication number Publication date
KR20030066732A (ko) 2003-08-09
CN1486368A (zh) 2004-03-31
CN100385005C (zh) 2008-04-30
US20090197337A1 (en) 2009-08-06
WO2002050289A1 (fr) 2002-06-27
EP1346056A1 (fr) 2003-09-24
WO2002050289A9 (fr) 2003-04-17
NZ526822A (en) 2005-03-24
JP4570327B2 (ja) 2010-10-27
CA2432315A1 (fr) 2002-06-27
JP2004527227A (ja) 2004-09-09
TWI317736B (en) 2009-12-01
EA009181B1 (ru) 2007-12-28
BR0116220A (pt) 2003-09-23
AR037083A1 (es) 2004-10-20
EA200300708A1 (ru) 2003-12-25
AU3281902A (en) 2002-07-01
WO2002050289A8 (fr) 2005-01-20
MXPA03005548A (es) 2004-04-20
AU2002232819B2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
AU3281902A (en) Methods for the production of multimeric proteins, and related compositions
AU2002232819A1 (en) Methods for the production of multimeric proteins, and related compositions
EP1660638A4 (fr) Lipoparticules comprenant des proteines, et procedes de production et d'utilisation de ces lipoparticules
GB0003079D0 (en) Novel protein
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
AU2001280436A1 (en) Process to increase protein stability
GB0125093D0 (en) Multimeric proteins
GB0011269D0 (en) Protein over expression
GB0123114D0 (en) Protein production
GB0001700D0 (en) Novel protein
AU2002326909A8 (en) Neurotransmission-associated proteins
GB0024770D0 (en) Multimeric proteins
ZA200210029B (en) Compositions and methods for the modification of gene expression.
GB0027675D0 (en) Protein Expression
GB0024283D0 (en) Novel proteins
GB0018126D0 (en) Novel proteins
GB0027449D0 (en) Novel proteins
GB0028971D0 (en) Novel proteins
GB0018125D0 (en) Novel proteins
GB0014173D0 (en) Novel protein
GB0004978D0 (en) Novel Protein
GB0012699D0 (en) Novel protein
GB0024448D0 (en) Novel Protein
GB0025447D0 (en) Novel protein
GB0025816D0 (en) Novel protein